Listed equity
Dr. Lal Pathlabs
डॉ लाल पैथलैब · ડૉ લાલ પૈથલેબ્સ
₹1620.30▼₹9.15(-0.55%)
EOD close · 3 Jul 2026
mid rallyneutral -10
Above 50- and 200-day MAs with +23.6% over 3 months — established uptrend.
52W low ₹1272.0052W high ₹1803.60
Now at 66% of its 52-week range
Long-term returns
1Y
+19.3%
3Y
+45.9%
5Y
-1.4%
10Y
+290.6%
Phase indicator
mid rally-10.2% from 52w high
Above 50- and 200-day MAs with +23.6% over 3 months — established uptrend.
1M
+4.7%
3M
+23.6%
1Y
+19.3%
Delivery conviction
neutralscore -10
Delivery vs 20-day avg0.92x
Lifetime story
Dr. Lal Pathlabs is up 365.3% from its lifetime low of ₹348.25 on 20 Jan 2016. ₹10,000 invested then would be worth ₹46,527 today (15.8% CAGR over 10.5 years). Lifetime high of ₹2121.50 was set on 15 Sept 2021 (currently -23.6% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
41% cheaper than industry(Industry P/E 92.5)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM) | 54.19 | 54.57 |
| P/B | 11.14 | 10.99 |
| Price / Cash flow | 41.59 | 41.32 |
| Dividend yield | 1.70% | 1.70% |
| Book value / share | 147.52 ₹ | 149.62 ₹ |
| EPS (TTM) | 30.32 ₹ | 30.11 ₹ |
Market cap
₹27.5K Cr
52W high
₹1803.60
16 Jun 2026
52W low
₹1272.00
23 Mar 2026
Returns ladder
1W
-2.8%
1M
+4.7%
3M
+23.6%
6M
+11.6%
YTD
+10.9%
1Y
+19.3%
3Y
+45.9%
5Y
-1.4%
10Y
+290.6%
Since listing
+298.7%